Literature DB >> 16449510

Directional atherectomy facilitates the interventional procedure and leads to a low rate of recurrent stenosis in left anterior descending and left circumflex artery ostium stenoses: subgroup analysis of the FLEXI-CUT study.

J B Dahm1, J Ruppert, S Hartmann, D Vogelgesang, A Hummel, S B Felix.   

Abstract

OBJECTIVES: To examine by retrospective analysis of data from the FLEXI-CUT monocentre registry whether atherectomy can effectively simplify complex stent implantation in ostial bifurcation lesions by reducing the procedure to stenting of the left anterior descending (LAD) or left circumflex (LCX) artery ostium alone. PATIENTS AND METHODS: All patients who had been enrolled in the prospective FLEXI-CUT study (directional atherectomy with adjunctive balloon angioplasty) were retrospectively analysed on the basis of significant LAD or LCX ostial stenosis (>or= 70% stenosis) deriving from an undiseased left main stem. The primary combined end point was the rate of target lesion revascularisation (TLR) and binary restenosis; secondary end points were procedural success and major adverse cardiac events (MACE) at the six-month follow up.
RESULTS: Of 30 patients enrolled with significant LAD or LCX ostium stenosis, 29 were effectively treated with directional atherectomy (96.7% procedural success). All patients underwent single-vessel stenting procedures of solely the LAD or LCX ostium. At follow up, binary stenosis was 25% (6 of 24), TLR (angiographic plus clinical) 10.3% (3 of 29) and total MACE 6.9% (2 of 29).
CONCLUSIONS: Directional atherectomy with single-vessel stenting procedures facilitates the interventional treatment of LAD and LCX ostium stenosis, and leads to remarkably low TLR and binary stenosis at follow up.

Entities:  

Mesh:

Year:  2006        PMID: 16449510      PMCID: PMC1861141          DOI: 10.1136/hrt.2005.081752

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

1.  Clinical and angiographic outcome of directional atherectomy followed by stent implantation in de novo lesions located at the ostium of the left anterior descending coronary artery.

Authors:  F Airoldi; C Di Mario; G Stankovic; C Briguori; M Carlino; A Chieffo; F Liistro; M Montorfano; P Pagnotta; V Spanos; D Tavano; A Colombo
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

2.  Stenting after directional coronary atherectomy compared with directional coronary atherectomy alone and stenting alone: a serial intravascular ultrasound study.

Authors:  Akio Kawamura; Yasushi Asakura; Shiro Ishikawa; Teruo Okabe; Akiko Yamane; Hui-Chong Li; Satoshi Ogawa
Journal:  Circ J       Date:  2004-05       Impact factor: 2.993

3.  Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty.

Authors:  M S Huber; J F Mooney; J Madison; M R Mooney
Journal:  Am J Cardiol       Date:  1991-08-15       Impact factor: 2.778

4.  'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS).

Authors:  C A Simonton; M B Leon; D S Baim; T Hinohara; K M Kent; R M Bersin; B H Wilson; G S Mintz; P J Fitzgerald; P G Yock; J J Popma; K K Ho; D E Cutlip; C Senerchia; R E Kuntz
Journal:  Circulation       Date:  1998-02-03       Impact factor: 29.690

5.  Effect of lesion characteristics on outcome of directional coronary atherectomy.

Authors:  T Hinohara; M H Rowe; G C Robertson; M R Selmon; L Braden; J H Leggett; J W Vetter; J B Simpson
Journal:  J Am Coll Cardiol       Date:  1991-04       Impact factor: 24.094

6.  Early and mid-term results of drug-eluting stent implantation in unprotected left main.

Authors:  Alaide Chieffo; Goran Stankovic; Erminio Bonizzoni; Eleftheria Tsagalou; Ioannis Iakovou; Matteo Montorfano; Flavio Airoldi; Iassen Michev; Massimo Giuseppe Sangiorgi; Mauro Carlino; Giancarlo Vitrella; Antonio Colombo
Journal:  Circulation       Date:  2005-02-07       Impact factor: 29.690

7.  One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  Circulation       Date:  2004-04-12       Impact factor: 29.690

8.  Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial.

Authors: 
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

9.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Authors:  Jeffrey W Moses; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; David R Holmes; Charles O'Shaughnessy; Ronald P Caputo; Dean J Kereiakes; David O Williams; Paul S Teirstein; Judith L Jaeger; Richard E Kuntz
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

10.  Frequency of success and complications of coronary angioplasty of a stenosis at the ostium of a branch vessel.

Authors:  D W Mathias; J F Mooney; H W Lange; I F Goldenberg; F L Gobel; M R Mooney
Journal:  Am J Cardiol       Date:  1991-03-01       Impact factor: 2.778

View more
  1 in total

1.  Long-term outcomes following ostial left anterior descending artery intervention with or without crossover to left-main.

Authors:  Osama Elkhateeb; Sunil Thambi; Hussein Beydoun; Helen Bishop; Ata Quraishi; Bakhtiar Kidwai; Lawrence Title
Journal:  Am J Cardiovasc Dis       Date:  2022-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.